An interactive mobile application versus an educational booklet to promote job retention in women undergoing adjuvant chemotherapy for breast cancer: a randomized controlled trial

Autor: Victoria S. Blinder, Sujata Patil, Jackie Finik, Della Makower, Monica Muppidi, Wendy G. Lichtenthal, Patricia A. Parker, Maria Claros, Jennifer Suarez, Bharat Narang, Francesca Gany

Publikováno v: Trials, Vol 23, Iss 1, Pp 1-22 (2022)

Abstract Background Job loss after a cancer diagnosis can lead to long-term financial toxicity and its attendant adverse clinical consequences, including decreased treatment adherence. Among women undergoing (neo)adjuvant chemotherapy for breast canc

Externí odkaz: https://doaj.org/article/b627acce9ae645048781c88496c44517

Lymphovascular invasion, race, and the 21-gene recurrence score in early estrogen receptor-positive breast cancer

Autor: Della Makower, Juan Lin, Xiaonan Xue, Joseph A. Sparano

Publikováno v: npj Breast Cancer, Vol 7, Iss 1, Pp 1-7 (2021)

Abstract Lymphovascular invasion (LVI) and Black race are associated with poorer prognosis in early breast cancer (EBC). We evaluated the association between LVI and race, and whether LVI adds prognostic benefit to the 21-gene recurrence score (RS) i

Externí odkaz: https://doaj.org/article/db1b4e3ce01c429cbcb8a0a40bb7e736

Abstract GS1-05: Trial Assigning Individualized Options for Treatment (TAILORx): An Update Including 12-Year Event Rates

Autor: Joseph Sparano, Robert J. Gray, Della Makower, Kathy S. Albain, Daniel F. Hayes, Charles Geyer, Elizabeth Dees, Matthew P. Goetz, John A. Olson, Tracy G. Lively, Sunil Badve, Thomas Saphner, Lynne I. Wagner, Timothy Whelan, Virginia Kaklamani, George Sledge

Publikováno v: Cancer Research. 83:GS1-05

Background: Late recurrence of breast cancer after 5 years accounts for about 50% of recurrences in hormone receptor (HR)-positive early breast cancer (EBC). TAILORx established non-inferiority of adjuvant endocrine therapy (ET) given for at least 5

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::af59260373050ed3d12fc7bdbec8549a
https://doi.org/10.1158/1538-7445.sabcs22-gs1-05

EZH2 Protein Expression in Triple-negative Breast Cancer Treated With Neoadjuvant Chemotherapy: An Exploratory Study of Association With Tumor Response and Prognosis

Autor: Susan, Fineberg, Xuejun, Tian, Della, Makower, Malini, Harigopal, Yungtai, Lo

Publikováno v: Applied Immunohistochemistry & Molecular Morphology. 30:157-164

Neaodjuvant chemotherapy is used to treat high risk triple-negative breast cancer (TNBC). Residual cancer burden (RCB) is used to predict risk of relapse after neoadjuvant chemotherapy (NAC); however, it cannot predict disease recurrence with certain

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d176b25ee7e6bf5f625c3ec5345d50f3
https://doi.org/10.1097/pai.0000000000000998

Contributors

Autor: Adesoye, Taiwo, Aebi, Stefan, Aizer, Ayal, Allweis, Tanir M., Arnold, Alicia Huff, Ashfaq, Raheela, Barrio, Andrea V., Bazan, Jose G., Bedrosian, Isabelle, Berkowitz, Alyssa, Bland, Kirby I., Aydi, Zeynep B., Braunstein, Lior Z., Brufsky, Adam, Cahlon, Oren, Carlson, Kjirsten A., Cass, Samuel, Cathcart-Rake, Elizabeth, Caudle, Abigail, Chen, Zhengshan, Chen, Chien, Childs, Daniel S., Chung, Alice, Cody, Hiram S., III, Coleman, Robert, Copeland, Edward M., III, Cox, Solange E., Cox, Dawn M., Czyz, Rebecca, David, Bre Ana, Degnim, Amy C., Dhakal, Ajay, Dietz, Jill R., Esgueva, Antonio J., Euhus, David M., Farr, Deborah E., Fayanju, Oluwadamilola M., Freedman, Gary M., Gallagher, Kristalyn K., Garvey, Patrick Bryan, Gass, Jennifer S., Geletzke, Abby K., Gemignani, Mary L., Giuliano, Armando E., Goldman, Kara N., Golshan, Mehra, Goodman, Chelain R., Gradishar, William J., Greenberg, Caprice C., Grobmyer, Stephen R., Grubstein, Ahuva, Gutnik, Lily, Harris, Eleanor E., Howard, Frederick M., Hunt, Kelly K., Jhawar, Sachin R., Jungheim, Emily S., Kaklamani, Virginia, Kalliath, Naomi J., Karuturi, Meghan S., Kass, Rena B., Khan, Seema A., Khan, Maryam I., Khan, Sadia, Suzanne Klimberg, V., Korourian, Soheila, Krishnamurthy, Jairam, Kuerer, Henry M., Kumarapeli, Asangi R., Kumbla, Pallavi A., Kumthekar, Priya, Lathrop, Kate I., Lee, Anne E., Marilyn Leitch, A., Liang, Diana, Lin, Nancy U., Linda Bi, Wenya, Lippe, Caroline E., Lu, Janice, Lustberg, Maryam, Ma, Emily, Ma, Yanling, Della Makower, Mallory, Melissa Anne, Mancino, Anne Thompson, Massoll, Nicole, Matalkah, Ahmad M., Matar, Regina, Mathew, Aju, McCormick, Beryl, McGuire, Kandace P., Mehra, Karishma, Mendez, Jane E., Menes, Tehillah, Merajver, Sofia D., Mhatre, Priya V., Mitchell, Sunny D., Morikawa, Aki, Muesse, Jason L., Nanda, Rita, Okoro, Stanley, O'Regan, Ruth M., Osipo, Clodia, Pariser, Ashley, Pastoriza, Jessica, Patel, Vijay, Pernas, Sonia, Piltin, Mara A., Pisano, Courtney E., Podoll, Mirna B., Post, Ginell R., Prati, Raquel, Press, Michael F., Pusztai, Lajos, Racz, Jennifer, Rivere, Amy E., Robinson, Angelica S., Rosenbloom, Arlan L., Rosso, Kelly J., Rozenblit, Mariya, Rubio, Isabel T., Ruddy, Kathryn J., Sanders, Melinda E., Sanft, Tara, Savalia, Nirav B., Schuetz, Steven J., Sener, Stephen F., Shah, Ami N., Shahpar, Samman, Shalin, Sara C., Siddiq, Namrah, Silverstein, Melvin J., Simpson, Ashley, Singhal, Dhruv, Smith, Benjamin D., Smith, Karen Lisa, Spanheimer, Philip M., Sparano, Joseph A., Spiguel, Lisa R.P., Stearns, Vered, Steliga, Matthew A., Sun, Susie X., Tarantino, Paolo, Tolaney, Sara M., De La Torre, Jorge I., Tsai, Jacqueline, Valente, Stephanie A., Sorice-Virk, Sarah, Vogel, Victor G., Wapnir, Irene L., Weiser, Roi, Yaney, Alex, Yellala, Amulya, Zanfagnin, Valentina

Publikováno v: In Bland and Copeland's The Breast: Comprehensive Management of Benign and Malignant Diseases Edition: Sixth Edition. 2024:vii-xiv